Peritoneal Cavity Cancer

• CLINICAL_TRIALS trial_result · 2023-04-03
  Clinical Trial Update: FT516 and IL2 With Enoblituzumab for Ovarian Cancer [Phase 1]

  Phase 1 clinical trial update for FT516 and IL-2 with enoblituzumab in ovarian cancer-related conditions, completed with results posted.

• CLINICAL_TRIALS trial_result · 2020-04-06
  Clinical Trial Update: Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer [Phase 2]

  Phase 2 clinical trial evaluating lurtotecan liposome in advanced or recurrent ovarian epithelial cancer has completed.

• CLINICAL_TRIALS trial_result · 2020-04-02
  Clinical Trial Update: Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]

  Phase 3 trial evaluating combination chemotherapy regimens for ovarian epithelial cancer, primary peritoneal cancer, and fallopian tube canc…

• CLINICAL_TRIALS trial_result · 2017-08-10
  Clinical Trial Update: Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer [Phase 2]

  Phase 2 clinical trial comparing intraperitoneal versus intravenous chemotherapy after neoadjuvant treatment in ovarian cancer has completed…

• CLINICAL_TRIALS trial_result · 2015-06-11
  Clinical Trial Update: Lapatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Peritoneal Cancer [Phase 2]

  A Phase 2 clinical trial updating on lapatinib for persistent or recurrent ovarian epithelial or peritoneal cancer has completed with result…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2010-02-08
  Clinical Trial Update: Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]

  Phase 2 trial evaluating carboplatin, paclitaxel, and surgery for advanced ovarian epithelial, fallopian tube, or primary peritoneal cancer;…